Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net income	$ 14,322	$ 4,147
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	9,268	8,864
Amortization of debt issuance costs	84	74
Provision for doubtful accounts	632	3,101
Share-based compensation	1,391	1,586
Deferred income taxes	397	388
Change in fair value of contingent consideration	4,584	16,881
Contingent consideration paid in excess of acquisition fair value	(2,089)	0
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(1,524)	(13,231)
Inventories	(78,828)	(53,089)
Prepaid expenses and other assets	(3,194)	(13,980)
Other non-current assets	124	4,401
Accounts payable	69,073	7,013
Accrued expenses and other liabilities	(4,115)	(3,006)
Income taxes payable	(4,411)	(535)
Net cash (used in) provided by operating activities	5,714	(37,386)
Cash flows from investing activities:
Capital expenditures	(990)	(1,310)
Cash paid for business acquisitions, net of cash acquired	(13,207)	(142,802)
Net cash (used in) investing activities	(14,197)	(144,112)
Cash flows from financing activities:
Borrowings on revolving credit	559,911	702,435
Repayments on revolving credit	(527,151)	(513,972)
Debt issuance costs	0	(296)
Repayments on long-term debt	(330)	0
Repayments on capital lease obligation	(165)	(141)
Contingent consideration payments	(30,158)	(40,858)
Exercise and issuance of equity awards	440	231
Taxes paid on settlement of equity awards	(15)	(38)
Net cash provided by financing activities	2,532	147,361
Effect of exchange rate changes on cash and cash equivalents	(721)	1,659
Decrease in cash and cash equivalents	(6,672)	(32,478)
Cash and cash equivalents at beginning of period	25,530	56,094
Cash and cash equivalents at end of period	$ 18,858	$ 23,616